http://rdf.ncbi.nlm.nih.gov/pubchem/patent/PL-432480-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a163c282a16b8df240c84d71a529355c
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-585
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
filingDate 2019-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08084a214f2f206e18f026c55097f960
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b8dde4ba534f92cd4df5f626970fa10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94cedfc14da824199ba3ff1b0d8fb320
publicationDate 2021-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber PL-432480-A1
titleOfInvention Preparation of eplerenone in the form of orodispersible tablets
abstract The subject of the application is a pharmaceutical preparation in the form of orodispersible tablets containing the active ingredient eplerenone or a pharmaceutically acceptable salt or solvate thereof produced by direct tabletting, with a disintegration time in the oral cavity of less than 40 seconds. The subject of the application is also a method for the preparation of a pharmaceutical preparation in the form of orally disintegrating tablets containing eplerenone, comprising the following steps: a) combining the active, filler, disintegrant and lubricant / glidant substance by mixing them to a homogeneous mixture, b) optionally, introducing them into blends of the remaining excipients, c) compressing the blend into tablets.
priorityDate 2019-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502867
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID443872

Total number of triples: 15.